Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19
View ORCID ProfileSang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, View ORCID ProfileDae Jung Kim
doi: https://doi.org/10.1101/2020.05.20.20108555
Sang Youl Rhee
1Department of Endocrinology and Metabolism, Kyung Hee University School of Medicine, Seoul, Korea
M.D., Ph.D.Jeongwoo Lee
2Data Science team, Hanmi Pharm. Co., Ltd., Seoul, Korea
B.S.Hyewon Nam
2Data Science team, Hanmi Pharm. Co., Ltd., Seoul, Korea
B.S.Dae-Sung Kyoung
2Data Science team, Hanmi Pharm. Co., Ltd., Seoul, Korea
M.Sc.Dae Jung Kim
3Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea
M.D.Article usage
Posted May 23, 2020.
Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19
Sang Youl Rhee, Jeongwoo Lee, Hyewon Nam, Dae-Sung Kyoung, Dae Jung Kim
medRxiv 2020.05.20.20108555; doi: https://doi.org/10.1101/2020.05.20.20108555
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (237)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4286)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2767)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4063)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1456)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)